Edward R. Conner - Net Worth and Insider Trading

Edward R. Conner Net Worth

The estimated net worth of Edward R. Conner is at least $27,888 dollars as of 2024-11-28. Edward R. Conner is the Sr. VP & Chief Medical Officer of Sangamo Therapeutics Inc and owns about 12,125 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $27,888. Edward R. Conner is also the Chief Medical Officer of Third Harmonic Bio Inc and owns about 0 shares of Third Harmonic Bio Inc (THRD) stock worth over $0. Details can be seen in Edward R. Conner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward R. Conner has not made any transactions after 2024-11-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Edward R. Conner

Edward R. Conner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward R. Conner owns 5 companies in total, including Imara Inc (IMRA) , Audentes Therapeutics Inc (BOLD) , and Sangamo Therapeutics Inc (SGMO) among others .

Click here to see the complete history of Edward R. Conner’s form 4 insider trades.

Insider Ownership Summary of Edward R. Conner

Ticker	Comapny	Transaction Date	Type of Owner
IMRA	Imara Inc	2020-04-22	director
BOLD	Audentes Therapeutics Inc	2020-01-15	SVP & Chief Medical Officer
SGMO	Sangamo Therapeutics Inc	2019-01-07	Senior VP & CMO
		2024-11-08	Chief Medical Officer
		2020-04-22	director

Edward R. Conner Latest Holdings Summary

Edward R. Conner currently owns a total of 2 stocks. Among these stocks, Edward R. Conner owns 12,125 shares of Sangamo Therapeutics Inc (SGMO) as of January 7, 2019, with a value of $27,888 and a weighting of 100%. Edward R. Conner also owns 0 shares of Third Harmonic Bio Inc (THRD) as of November 8, 2024, with a value of $0 and a weighting of 0%.

Latest Holdings of Edward R. Conner

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SGMO	Sangamo Therapeutics Inc	2019-01-07	12,125	2.30	27,888
THRD	Third Harmonic Bio Inc	2024-11-08	0	13.11	0

Holding Weightings of Edward R. Conner

Edward R. Conner Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward R. Conner has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 5,000 shares on January 7, 2019, which brought Edward R. Conner around $61,650.

According to the SEC Form 4 filings, Edward R. Conner has made a total of 4 transactions in Third Harmonic Bio Inc (THRD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Third Harmonic Bio Inc is the sale of 2,117 shares on November 8, 2024, which brought Edward R. Conner around $31,755.

Insider Trading History of Edward R. Conner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward R. Conner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward R. Conner Ownership Network

Ownership Network List of Edward R. Conner

No Data

Ownership Network Relation of Edward R. Conner

Edward R. Conner Owned Company Details

What does Imara Inc do?

Who are the key executives at Imara Inc?

Edward R. Conner is the director of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .

Imara Inc (IMRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Imara Inc Insider Transactions

No Available Data

What does Audentes Therapeutics Inc do?

Who are the key executives at Audentes Therapeutics Inc?

Edward R. Conner is the SVP & Chief Medical Officer of Audentes Therapeutics Inc. Other key executives at Audentes Therapeutics Inc include President and COO Natalie C. Holles , Executive Vice President & CFO Thomas P Soloway , and SVP & Chief Commercial Officer Eric Mosbrooker .

Audentes Therapeutics Inc (BOLD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Audentes Therapeutics Inc (BOLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Audentes Therapeutics Inc (BOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Audentes Therapeutics Inc (BOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Audentes Therapeutics Inc Insider Transactions

No Available Data

What does Sangamo Therapeutics Inc do?

Who are the key executives at Sangamo Therapeutics Inc?

Edward R. Conner is the Senior VP & CMO of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .

Sangamo Therapeutics Inc (SGMO) Insider Trades Summary

Over the past 18 months, Edward R. Conner made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.

Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sangamo Therapeutics Inc Insider Transactions

No Available Data

What does Third Harmonic Bio Inc do?

Who are the key executives at Third Harmonic Bio Inc?

Edward R. Conner is the Chief Medical Officer of Third Harmonic Bio Inc. Other key executives at Third Harmonic Bio Inc include other: See Explanation of Responses Biotechnology Value Fund L P , Chief Administrative Officer Julie Person , and director & CEO Natalie C. Holles .

Third Harmonic Bio Inc (THRD) Insider Trades Summary

Over the past 18 months, Edward R. Conner made 4 insider transaction in Third Harmonic Bio Inc (THRD) with a net sale of 14,370. Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,970 shares made by Julie Person , a net sale of 25,114 shares made by , and a net sale of 33,780 shares made by Natalie C. Holles .

In summary, during the past 3 months, insiders sold 1,019,580 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 1,019,580 shares. During the past 18 months, 1,107,234 shares of Third Harmonic Bio Inc (THRD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,107,234 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Third Harmonic Bio Inc Insider Transactions

No Available Data

What does Enliven Therapeutics Inc do?

Who are the key executives at Enliven Therapeutics Inc?

Edward R. Conner is the director of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Financial Officer Benjamin Hohl , director & President and CEO Samuel Kintz , and Chief Operating Officer Anish Patel .

Enliven Therapeutics Inc (ELVN) Insider Trades Summary

Over the past 18 months, Edward R. Conner made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 240,342 shares made by Samuel Kintz , a net sale of 239,847 shares made by Joseph P Lyssikatos , and a net sale of 88,314 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 165,839 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 165,839 shares. During the past 18 months, 4,855,709 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,855,709 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enliven Therapeutics Inc Insider Transactions

No Available Data

Edward R. Conner Mailing Address

Above is the net worth, insider trading, and ownership report for Edward R. Conner. You might contact Edward R. Conner via mailing address: 501 Canal Blvd., Point Richmond Tech Center, Richmond Ca 94804.

Discussions on Edward R. Conner

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.